Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in Inflammation and Disease: Mechanisms, Therapeutic Potential, and Future Directions
International Journal of Molecular Sciences · 25.10.2025 · 26 (21) · 10386
DOI: 10.3390/ijms262110386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2025. Verfasst von Neerja Trivedi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, NE 68178, USA. Hauptthemen laut MEDLINE: Triggering Receptor Expressed on Myeloid Cells-1, Inflammation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Creighton University, Cognitive Neuroscience of Development and Aging (CoNDA) Center, NIGMS-Creighton University CoBRE Program grant.
Abstract (Originalsprache)
Triggering receptor expressed on myeloid cells-1 (TREM-1), a member of the immunoglobulin superfamily, plays a crucial role in amplifying inflammatory responses, thereby contributing to the pathogenesis and progression of various inflammatory diseases. This review presents a comprehensive analysis of the current understanding of TREM-1 signaling and its dysregulation in disease pathology. Additionally, it explores the prognostic significance of TREM-1 across a spectrum of conditions. Targeting TREM-1 signaling represents a promising therapeutic approach for managing a wide range of diseases, including cancer, neurodegenerative disorders, cardiovascular diseases, and other inflammation-driven conditions. Previous reviews on TREM-1 have largely focused on its immunological role across diverse disease conditions and selective peptide-based inhibitors targeting its signaling pathway. However, recent discoveries have identified small-molecule modulators of TREM-1 that offer new opportunities for therapeutic intervention. Incorporating these findings would provide a more comprehensive and updated perspective on TREM-1 biology, particularly regarding its molecular regulation, drug-target potential, and translational relevance in inflammatory and immune-mediated disorders. Advances in this field are expected to be driven by structure-based drug design, particularly in the development of TREM-1 inhibitors. However, further research is needed to elucidate the predictive value of TREM-1 alterations and to evaluate them in prospective human studies prior to clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Neuroscience, School of Medicine, Creighton University, Omaha, NE 68178, USA.
- Department of Pharmacology, Bharati Vidyapeeth Deemed University Medical College, Pune 411043, Maharashtra, India.
ORCID-Profile: Neerja Trivedi, Jitendra D Bhosale, Amit Pant, Prerna Tiwari, Gopal P Jadhav
Förderung
- Creighton University
- Cognitive Neuroscience of Development and Aging (CoNDA) Center
- NIGMS-Creighton University CoBRE Program grant
Zitieren
APA
Trivedi, N., Bhosale, J. D., Pant, A., Suryawanshi, S. P., Tiwari, P., Abel, P. W., & Jadhav, G. P. (2025). Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in Inflammation and Disease: Mechanisms, Therapeutic Potential, and Future Directions. International Journal of Molecular Sciences, 26(21), 10386. https://doi.org/10.3390/ijms262110386
Vancouver
Trivedi N, Bhosale JD, Pant A, Suryawanshi SP, Tiwari P, Abel PW, et al. Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in Inflammation and Disease: Mechanisms, Therapeutic Potential, and Future Directions. International Journal of Molecular Sciences. 2025;26(21):10386. doi:10.3390/ijms262110386
BibTeX
@article{Trivedi2025,
author = {Trivedi, Neerja and Bhosale, Jitendra D and Pant, Amit and Suryawanshi, Sonali P and Tiwari, Prerna and Abel, Peter W and Jadhav, Gopal P},
title = {Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in Inflammation and Disease: Mechanisms, Therapeutic Potential, and Future Directions},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10386},
doi = {10.3390/ijms262110386}
}
EUVIMED